Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • The cGAS-STING pathway: DNA sensing in health and disease (Jun 2026)
    • Neurodegeneration (Mar 2026)
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Recent advances in the molecular pathophysiology of atrial fibrillation
Reza Wakili, Niels Voigt, Stefan Kääb, Dobromir Dobrev, Stanley Nattel
Reza Wakili, Niels Voigt, Stefan Kääb, Dobromir Dobrev, Stanley Nattel
View: Text | PDF
Science in Medicine

Recent advances in the molecular pathophysiology of atrial fibrillation

  • Text
  • PDF
Abstract

Atrial fibrillation (AF) is an extremely common cardiac rhythm disorder that causes substantial morbidity and contributes to mortality. The mechanisms underlying AF are complex, involving both increased spontaneous ectopic firing of atrial cells and impulse reentry through atrial tissue. Over the past ten years, there has been enormous progress in understanding the underlying molecular pathobiology. This article reviews the basic mechanisms and molecular processes causing AF. We discuss the ways in which cardiac disease states, extracardiac factors, and abnormal genetic control lead to the arrhythmia. We conclude with a discussion of the potential therapeutic implications that might arise from an improved mechanistic understanding.

Authors

Reza Wakili, Niels Voigt, Stefan Kääb, Dobromir Dobrev, Stanley Nattel

×

Figure 2

Cellular mechanisms underlying focal ectopic activity.

Options: View larger image (or click on image) Download as PowerPoint
Cellular mechanisms underlying focal ectopic activity.
(A) The normal at...
(A) The normal atrial action potential (transmembrane potential as a function of time, in black) has a stable resting value close to –80 mV. Cell firing causes rapid depolarization (phase 0) to a positive value. Following initial repolarization, there is a flat (plateau) phase and then repolarization back to the resting potential. Normal atrial cells remain at the resting potential until they are fired through the SA node pacemaking system. Abnormal atrial automaticity results from spontaneous diastolic depolarization to a threshold value for activation. (B and C) Afterdepolarizations: abnormal membrane depolarizations after completion of the AP. DADs occur after full repolarization (B); EADs precede full repolarization (C). (D) Fundamental mechanisms leading to DADs, the most important source of ectopic activity in AF. DADs result from spontaneous diastolic SR Ca2+ releases through channels called RyR2s. RyR2s are sensitive to intra-SR free Ca2+ concentration. Abnormal diastolic RyR2 Ca2+ releases can result from excess SR intraluminal Ca2+ (pumped into the SR by SERCA) or reduced SR Ca2+ binding by the principal SR Ca2+ buffer, calsequestrin (CSQ). RyR2 hyperphosphorylation increases sensitivity to SR Ca2+, causing abnormal RyR2 Ca2+ release events. Diastolic RyR2 Ca2+ release increases cytosolic Ca2+, which has to be removed by the NCX. NCX moves three Na+ ions into the cell in exchange for each Ca2+ ion moved out, creating an inward movement of positive charges that produces a depolarizing Iti. Repolarizing conductances oppose Iti, protecting against excessive diastolic membrane voltage oscillations.

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts